Skip to main content
. 2018 Jun 1;40(5):1335–1341. doi: 10.1007/s11096-018-0654-4

Fig. 2.

Fig. 2

Numbers of patients with normal and abnormal scores at baseline and week 12 in the HADS anxiety subscale (scores of 0–7 are considered normal, 8–10 borderline, and ≥ 11 indicate clinical caseness); *two-sided p value for likelihood score test for changes over time (modelled by GEEs for ordinal responses) = 0.005 for EGb 761® (non-significant (n.s.) at p = 0.105 for pentoxifylline)